Loading live market data…

Mirum Pharmaceuticals, Inc.

NASDAQ:MIRM

$120.89 USD

$1.85 (1.55%)

Volume
714.99K
Average Volume
1M
Market Capitalization
$6.07B
P/E Ratio
-8.88
Dividend Yield
0.00%
Price Target
$145.50
Year High
$130.00
Year Low
$50.25
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$2.09

MIRM Estimated and Actual Revenue by Quarter

MIRM Estimated and Actual EPS by Quarter

MIRM Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 7 -124.95M -121.74M -123.65M -132.63M -129.22M -131.25M
2027-09-30 4 -116.96M -113.96M -115.74M -124.14M -120.96M -122.85M
2027-06-30 6 -109.55M -106.73M -108.41M -116.28M -113.29M -115.07M
2027-03-31 4 -104.49M -101.8M -103.4M -110.91M -108.06M -109.75M
2026-12-31 7 -101.5M -98.89M -100.44M -107.73M -104.97M -106.61M
2026-09-30 8 -98.98M -96.52M -97.78M -105.06M -102.45M -103.78M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 7 -1.14M -1.1M -1.12M 262.18M 269.09M 266.29M
2027-09-30 4 -11.78M -11.39M -11.63M 245.41M 251.88M 249.25M
2027-06-30 6 -20.84M -20.15M -20.56M 229.86M 235.92M 233.46M
2027-03-31 4 -25.09M -24.25M -24.75M 219.24M 225.02M 222.67M
2026-12-31 7 -45.02M -43.52M -44.41M 212.97M 218.58M 216.3M
2026-09-30 8 -73.34M -11.66M -39.34M 207.86M 213.16M 210.57M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 7 213.98M 219.62M 217.34M 1 -0.01933609 -0.01869257 -0.019075
2027-09-30 4 200.3M 205.58M 203.43M 1 -0.20025 -0.19359 -0.19755
2027-06-30 6 187.6M 192.55M 190.54M 1 -0.35415 -0.34237 -0.34937
2027-03-31 4 178.94M 183.65M 181.74M 1 -0.42633 -0.41214 -0.42057
2026-12-31 7 173.82M 178.4M 176.54M 1 -0.76496 -0.7395 -0.75463
2026-09-30 8 169.65M 173.98M 171.86M 5 -1.24625 -0.19808 -0.66852